Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 46, 731-736, May 1998, Copyright  1998, The Histochemical Society, Inc. 

Phrase: "46,"

Phrase: "731-736,"

Phrase: "May 1998,"

Phrase: "Copyright  1998,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine Mark A. 

Phrase: "ARTICLE Cytochemical Demonstration of Oxidative Damage"

Phrase: "in Alzheimer Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "by Immunochemical Enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   861   C2349975:Enhancement [Activity]

Phrase: "of the Carbonyl Reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "with 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-Dinitrophenylhydrazine Mark A."
Processing 00000000.tx.4: Smitha, Lawrence M. 

Phrase: "Smitha,"

Phrase: "Lawrence M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: Sayreb, Vernon E. 

Phrase: "Sayreb,"

Phrase: "Vernon E."
Processing 00000000.tx.6: Andersonc, Peggy L.R. 

Phrase: "Andersonc,"

Phrase: "Peggy L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.7: Harrisa, M. 

Phrase: "Harrisa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.8: Flint Beald, Neil Kowalle, and George Perrya a Institute of Pathology, Case Western Reserve University, Cleveland, Ohio b Department of Chemistry, Case Western Reserve University, Cleveland, Ohio c Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio d Department of Neurology, Harvard Medical School, Boston, Massachusetts e Department of Veterans Affairs, Bedford, Massachusetts Correspondence to: Mark A. 

Phrase: "Flint Beald,"

Phrase: "Neil Kowalle,"

Phrase: "and"

Phrase: "George Perrya"

Phrase: "a Institute of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio b Department of Chemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio c Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio d Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587475:Neurology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts e Department of Veterans Affairs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   827   C1549054:Veterans Affairs [Organization]
   799   C0042610:Veterans [Population Group]
   799   C1704729:Department [Organization]
   766 E C3245459:veteran [Intellectual Product]

Phrase: "Bedford,"

Phrase: "Massachusetts Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Mark A."
Processing 00000000.tx.9: Smith, Inst. of Pathology, Case Western Reserve U., 2085 Adelbert Road, Cleveland, OH 44106. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "Inst."

Phrase: "of Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "Case Western Reserve U.,"

Phrase: "2085 Adelbert Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]
Processing 00000000.tx.10: Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited Formation of carbonyls derived from lipids, proteins, carbohydrates, and nucleic acids is common during oxidative stress. 

Phrase: "Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Formation of carbonyls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "derived from lipids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0023779:Lipids [Lipid]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "carbohydrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007004:Carbohydrates [Carbohydrate]

Phrase: "and"

Phrase: "nucleic acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acids [Chemical]
   861   C0007610:Nucleic [Cell Component]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "common during oxidative stress."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]
Processing 00000000.tx.11: For example, metal-catalyzed, "site-specific" oxidation of several amino acid side-chains produces aldehydes or ketones, and peroxidation of lipids generates reactive aldehydes such as malondialdehyde and hydroxynonenal. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "metal-catalyzed, ""site-specific"" oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030011:Oxidation [Molecular Function]

Phrase: "of several amino acid side-chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0337112:chains [Manufactured Object]
   804   C0441987:Side [Spatial Concept]
   804   C1524075:Chains [Idea or Concept]

Phrase: "produces"

Phrase: "aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001992:Aldehydes [Organic Chemical]

Phrase: "or"

Phrase: "ketones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022634:Ketones [Organic Chemical]

Phrase: "and"

Phrase: "peroxidation of lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0023775:Lipid Peroxidation [Molecular Function]
   790   C0178796:peroxidation [Phenomenon or Process]

Phrase: "generates"

Phrase: "reactive aldehydes such as malondialdehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001992:Aldehydes [Organic Chemical]

Phrase: "and"

Phrase: "hydroxynonenal."
Processing 00000000.tx.12: Here, using in situ 2,4-dinitrophenylhydrazine labeling linked to an antibody system, we describe a highly sensitive and specific cytochemical technique to specifically localize biomacromolecule-bound carbonyl reactivity. 

Phrase: "Here,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0444498:In situ [Spatial Concept]

Phrase: "4-dinitrophenylhydrazine labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "linked to an antibody system,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "we"

Phrase: "describe"

Phrase: "a highly sensitive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439822:Highly sensitive [Qualitative Concept]
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "specific cytochemical technique to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449851:Technique [Functional Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "biomacromolecule-bound carbonyl reactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   741   C0205332:Reactive [Qualitative Concept]
Processing 00000000.tx.13: When this technique was applied to tissues from cases of Alzheimer disease, in which oxidative events including lipoperoxidative, glycoxidative, and other oxidative protein modifications have been reported, we detected free carbonyls not only in the disease-related intraneuronal lesions but also in other neurons. 

Phrase: "When"

Phrase: "this technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "applied to tissues"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040300:Tissues [Tissue]
   790   C0185125:Applied [Health Care Activity]
   756 E C1547928:Tissue [Intellectual Product]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "from cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in which oxidative events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lipoperoxidative, glycoxidative,"

Phrase: "and"

Phrase: "other oxidative protein modifications"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0033666:Protein Modification [Molecular Function]
   884   C2263112:protein modification [Molecular Function]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "free carbonyls"

Phrase: "not only in the disease-related intraneuronal lesions"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C1546988:Not related [Idea or Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205171:Only [Quantitative Concept]
   744   C0221198:lesions [Finding]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1518422:Not [Functional Concept]
   744   C1720467:Only [Intellectual Product]
   711 E C1546698:Lesion [Intellectual Product]

Phrase: "but"

Phrase: "also in other neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]
Processing 00000000.tx.14: In marked contrast, free carbonyls were not found in neurons or glia in age-matched control cases. 

Phrase: "In marked contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "free carbonyls"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found in neurons"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or"

Phrase: "glia in age-matched control cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027836:Glia [Cell]
   753   C1087003:Glia [Plant]
Processing 00000000.tx.15: Importantly, this assay was highly specific for detecting disease-related oxidative damage because the site of oxidative damage can be assessed in the midst of concurrent age-related increases in free carbonyls in vascular basement membrane that would contaminate biochemical samples subjected to bulk analysis. 

Phrase: "Importantly,"

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "highly specific for detecting disease-related oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "the site of oxidative damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "assessed in the midst of concurrent age-related increases"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0001779:Age [Organism Attribute]
   742   C0205420:Concurrent [Temporal Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0442805:increases [Functional Concept]
   742   C0445223:Related [Finding]
   742   C1516048:Assessed [Activity]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "in free carbonyls"

Phrase: "in vascular basement membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0004799:Basement membrane [Tissue]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C1979853:Basement [Cell Component]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "that"

Phrase: "would"

Phrase: "contaminate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205279:contaminate [Functional Concept]

Phrase: "biochemical samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "subjected to bulk analysis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0012173:Bulk [Food]
   770   C0936012:Analysis [Research Activity]
   770   C1337615:Bulk [Biomedical or Dental Material]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.16: These findings demonstrate that oxidative imbalance and stress are key elements in the pathogenesis of Alzheimer disease. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that oxidative imbalance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1397014:Imbalance [Sign or Symptom]

Phrase: "and"

Phrase: "stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "are"

Phrase: "key elements in the pathogenesis of Alzheimer disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.17: (J Histochem Cytochem 46:731735, 1998) Key Words: Alzheimer disease, carbonyls, 2,4-dinitrophenylhydrazine, oxidative damage Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited Although oxidative stress and consequent free radical damage are involved as a major cytopathological mechanism in a number of diseases and in normal aging, methods to document free radical involvement have not grown at the same rate as hypotheses. 

Phrase: "(J Histochem Cytochem 46"

Phrase: ":"

Phrase: "731735,"

Phrase: "1998"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "carbonyls,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-dinitrophenylhydrazine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "oxidative damage Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Although"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "consequent free radical damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "are"

Phrase: "involved as a major cytopathological mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205164:Major [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "and in normal aging,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001811:Ageing [Organism Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "free radical involvement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1314939:Involvement [Functional Concept]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "grown at the same rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0445247:Same [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as hypotheses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.18: This gap has stemmed primarily from problems in quantifying free radicals in vivo, because they are rapidly removed by antioxidants or quenched by reaction with biopolymers. 

Phrase: "This gap"

Phrase: "has"

Phrase: "stemmed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242767:Stem [Plant]
   966   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "primarily from problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1546466:Problems [Idea or Concept]
   756 E C0033213:Problem [Finding]

Phrase: "in quantifying free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0302912:radicals [Chemical Viewed Structurally]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0439807:Radical [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "because"

Phrase: "they"

Phrase: "are"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed by antioxidants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "or"

Phrase: "quenched by reaction"

Phrase: "with biopolymers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005554:Biopolymers [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.19: In addition, normal metabolism generates abundant free radicals, such that detecting them without knowing the balance of oxidants and antioxidants is not biologically meaningful. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "normal metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "generates"

Phrase: "abundant free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   827   C0302912:radicals [Chemical Viewed Structurally]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0439807:Radical [Qualitative Concept]

Phrase: "such"

Phrase: "that detecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0442726:detect [Finding]

Phrase: "them without knowing"

Phrase: "the balance of oxidants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "is"

Phrase: "not biologically meaningful."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0876919:Meaning [Idea or Concept]
Processing 00000000.tx.20: This aspect has been circumvented by methods to detect excess radical production. 

Phrase: "This aspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547011:Aspect [Quantitative Concept]
  1000   C1879746:Aspect [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "circumvented by methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "excess radical production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.21: Although detection can be performed using exogenous agents that are specifically modified by free radicals, such as spin traps (Young et al. 1996 ), endogenous macromolecules can also be used as indicators because protein, DNA, and lipids are all chemically changed by oxidative stress (Stadtman 1993 ). 

Phrase: "Although"

Phrase: "detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "exogenous agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "specifically"

Phrase: "modified by free radicals,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   833   C0205349:Modified By [Qualitative Concept]
   802   C0559248:Modified radical [Qualitative Concept]
   770   C0302912:radicals [Chemical Viewed Structurally]
   770   C0332296:free [Functional Concept]
   770   C0392747:Modified [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   737 E C0439807:Radical [Qualitative Concept]

Phrase: "such as spin traps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0184047:traps [Medical Device]

Phrase: "(Young et al. 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332239:Young [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "endogenous macromolecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "used as indicators"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0021212:Indicators [Indicator, Reagent, or Diagnostic Aid]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1235732:Indicator [Bird]
   756 E C1522602:Indicator [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "are"

Phrase: "all chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "changed by oxidative stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "(Stadtman 1993"

Phrase: ")."
Processing 00000000.tx.22: Modifications of proteins and polynucleotides take two forms: (a) adduction reactions by highly reactive intermediate products of lipid peroxidation or glycation, and (b) direct oxidative modification of the macromolecules. 

Phrase: "Modifications of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   824   C0033666:Protein Modification [Molecular Function]
   824   C2263112:protein modification [Molecular Function]
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "polynucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032550:Polynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "two forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: ":"

Phrase: "(a) adduction reactions by highly reactive intermediate products of lipid peroxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0443286:Reaction [Functional Concept]
   704   C1114821:Reaction [Clinical Attribute]

Phrase: "or"

Phrase: "glycation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598528:glycation [Phenomenon or Process]

Phrase: "and ("

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "oxidative modification of the macromolecules."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2752381:macromolecule modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.23: In the case of proteins, powerful oxidizing agents such as the hydroxyl radical directly modify amino acid side-chains, resulting in a diverse array of altered amino acids that are used to assess oxidative damage (Stadtman 1993 ). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "powerful oxidizing agents such as the hydroxyl radical directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0085403:Oxidizing Agents [Chemical Viewed Functionally]
   708   C0030011:oxidize [Molecular Function]
   708   C0450442:Agent [Chemical Viewed Functionally]
   708   C1254351:Agent [Pharmacologic Substance]
   708   C1521826:Agent [Intellectual Product]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "amino acid side-chains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:chains [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chains [Idea or Concept]

Phrase: "resulting in a diverse array of altered amino acids"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0332294:Resulting in [Functional Concept]
   742   C0001128:Acids [Chemical]
   742   C0392747:Altered [Functional Concept]
   742   C0678226:resulting [Functional Concept]
   742   C1510941:Array [Spatial Concept]
   742   C1880371:Diverse [Qualitative Concept]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "(Stadtman 1993"

Phrase: ")."
Processing 00000000.tx.24: Among the most widespread of these modifications, and one that is considered specific for oxidative damage, is the generation of free carbonyls that are not present on nonoxidized proteins (Levine et al. 1994 ). 

Phrase: "Among the most widespread"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205391:Widespread [Spatial Concept]

Phrase: "of these modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "specific for oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "the generation of free carbonyls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "that"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present on nonoxidized proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(Levine et al. 1994"

Phrase: ")."
Processing 00000000.tx.25: 2,4-Dinitrophenylhydrazine (DNP-H) reacts with free carbonyls and can therefore serve as a marker for the extent of oxidative damage to a given protein (Szweda et al. 1993 ). 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-Dinitrophenylhydrazine (DNP-H)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "reacts with free carbonyls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "therefore"

Phrase: "serve as a marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Marker [Clinical Attribute]

Phrase: "for the extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "to a given protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Szweda et al. 1993"

Phrase: ")."
Processing 00000000.tx.26: However, although this method has been validated as an indicator of oxidative damage for a number of tissues and isolated proteins (Smith et al. 1991 ), the procedure does not provide histological resolution. 

Phrase: "However,"

Phrase: "although"

Phrase: "this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "validated as an indicator of oxidative damage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0010957:Damage [Injury or Poisoning]
   748   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   748   C0311404:Oxidative [Functional Concept]
   748   C1235732:Indicator [Bird]
   748   C1522602:Indicator [Functional Concept]
   748   C1883709:Damage [Functional Concept]

Phrase: "for a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "isolated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Smith et al. 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "the procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "histological resolution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514893:Resolution [Idea or Concept]
   861   C1706463:Resolution [Quantitative Concept]
   861   C2699488:Resolution [Conceptual Entity]
Processing 00000000.tx.27: Such cellular localization is essential for analysis of tissue when one considers that the vascular basement membrane and extracellular matrix proteins, which can contaminate many biochemical samples, contain abundant oxidative modifications as a consequence of their long half-lives. 

Phrase: "Such cellular localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660642:cellular localisation [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "essential for analysis of tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "when"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "considers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "that"

Phrase: "the vascular basement membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0004799:Basement membrane [Tissue]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C1979853:Basement [Cell Component]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "extracellular matrix proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079323:Extracellular Matrix Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "which"

Phrase: "can"

Phrase: "contaminate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205279:contaminate [Functional Concept]

Phrase: "many biochemical samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "abundant oxidative modifications as a consequence of their long half-lives."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0392747:Modification [Functional Concept]
   704   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.28: Here we report a highly specific and sensitive method to cytologically define oxidative damage that is based on the DNP-H reaction with free carbonyls but involves subsequent immunocytochemical enhancement. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a highly specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "sensitive method to cytologically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "define"

Phrase: "oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311404:Oxidative [Functional Concept]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "based on the DNP-H reaction"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1120216:dinitrophenylhydrazine [Organic Chemical]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "with free carbonyls"

Phrase: "but"

Phrase: "involves"

Phrase: "subsequent immunocytochemical enhancement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   827   C2349975:Enhancement [Activity]
Processing 00000000.tx.29: The technique is demonstrated using tissue sections from cases of Alzheimer disease and controls, because glycoxidative and lipoperoxidative damage are well documented in the pathological lesions of Alzheimer disease, neurofibrillary tangles and senile plaques (Yan et al. 1994 ; Smith et al. 1994 , Smith et al. 1995a , Smith et al. 1995b , Smith et al. 1996 , Smith et al. 1997 ; Montine et al. 1996 ; Sayre et al. 1997 ). 

Phrase: "The technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "is"

Phrase: "demonstrated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "tissue sections from cases of Alzheimer disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C2316368:Tissue section [Tissue]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "because"

Phrase: "glycoxidative"

Phrase: "and"

Phrase: "lipoperoxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "are"

Phrase: "well documented in the pathological lesions of Alzheimer disease,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0205170:Well [Qualitative Concept]
   742   C1301725:Documented [Health Care Activity]
   742   C1609436:documented [Idea or Concept]
   742   C3146287:Well [Manufactured Object]
   708 E C1301746:document [Intellectual Product]
   708 E C1547673:Document [Intellectual Product]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(Yan et al. 1994"

Phrase: "; Smith et al. 1994 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: "Smith et al. 1995a ,"

Phrase: "Smith et al. 1995b ,"

Phrase: "Smith et al. 1996 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: "Smith et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: "; Montine et al. 1996"

Phrase: "; Sayre et al. 1997"

Phrase: ")."
Processing 00000000.tx.30: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited Tissue The hippocampus extending from the entorhinal cortex to the full hippocampus from six cases of Alzheimer disease (ages 7690), three age-matched controls (ages 7078), and three younger controls (ages 3264) was fixed in Methacarn (methanol:chloroform:acetic acid 60:30:10) at 4C for 24 hr. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "The hippocampus extending from the entorhinal cortex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439792:Extending [Spatial Concept]
   714 E C0231448:Extend [Functional Concept]

Phrase: "to the full hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "from six cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(ages 7690"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "three age-matched controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0001779:Age [Organism Attribute]
   812   C0150103:matched [Research Activity]
   812   C1708943:Matched [Qualitative Concept]
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "(ages 7078"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "three younger controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(ages 3264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "fixed in Methacarn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0066069:methacarn [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "(methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "chloroform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ":"

Phrase: "acetic acid 60"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "30"

Phrase: ":"

Phrase: "10"

Phrase: ")"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 24 hr."
Processing 00000000.tx.31: Tissue was dehydrated through ascending ethanol solutions and xylene and then embedded in paraffin (~60C). 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "dehydrated through ascending ethanol solutions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001962:Ethanol [Organic Chemical]
   760   C0011175:Dehydrated [Disease or Syndrome]
   760   C0037633:Solutions [Substance]
   760   C0205385:Ascending [Qualitative Concept]
   760   C1547175:Ascending [Functional Concept]
   760   C1962987:Ascending [Functional Concept]
   726 E C0308355:ASCEND [Organic Chemical,Pharmacologic Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "embedded in paraffin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "(~60C"

Phrase: ")."
Processing 00000000.tx.32: Sections of 6 m sections were prepared with a microtome (Leica), placed on Silane-coated glass slides (Sigma; St Louis, MO), and sequentially deparaffinized in xylene and rehydrated in descending ethanol. 

Phrase: "Sections of 6 m sections"

Phrase: "were"

Phrase: "prepared with a microtome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0181856:microtome [Medical Device]
   770   C0700320:microtome [Laboratory Procedure]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(Leica"

Phrase: ")"

Phrase: ","

Phrase: "placed on Silane-coated glass slides"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0017596:Glass [Manufactured Object]
   753   C0178847:silane [Inorganic Chemical]
   753   C0444330:slides [Research Device]
   753   C1522408:Coated [Qualitative Concept]
   753   C1947936:Glass [Medical Device]
   719   C0442504:Place [Spatial Concept]
   719 E C0453946:Coat [Manufactured Object]
   719   C1704765:Place [Functional Concept]
   719 E C1705201:Slide [Manufactured Object]
   719   C1882509:Place [Activity]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
   719   C3496241:place [Disease or Syndrome]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "; St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "sequentially"

Phrase: "deparaffinized in xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "rehydrated in descending ethanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001962:Ethanol [Organic Chemical]
   770   C0205386:Descending [Qualitative Concept]
   770   C1547177:Descending [Qualitative Concept]
Processing 00000000.tx.33: Endogenous peroxidase activity was inactivated by treating with 3% H2O2 in methanol for 20 min to block artifactual staining from endogenous peroxidase activity (Sternberger 1986 ). 

Phrase: "Endogenous peroxidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151518:peroxidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "inactivated by treating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treating [Therapeutic or Preventive Procedure]
   790   C1522326:Treating [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with 3% H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "in methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "for 20 min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "artifactual staining from endogenous peroxidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(Sternberger 1986"

Phrase: ")."
Processing 00000000.tx.34: Although H2O2 might itself, or synergistically with tissue-bound iron, create carbonyl residues, deletion of this step had no effect on subsequent DNP-H labeling for the experiments shown here. 

Phrase: "Although"

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "might"

Phrase: "itself,"

Phrase: "or"

Phrase: "synergistically with tissue-bound iron,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0040300:Tissue [Tissue]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0332297:bound [Spatial Concept]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1145667:Bound [Activity]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1167622:Bound [Molecular Function]
   760   C1547928:Tissue [Intellectual Product]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "carbonyl residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "deletion of this step"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "had"

Phrase: "no effect on subsequent DNP-H labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "for the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here."
Processing 00000000.tx.35: However, a control that omits the H2O2 treatment step should be performed with each experimental paradigm. 

Phrase: "However,"

Phrase: "a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "omits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omit [Idea or Concept]

Phrase: "the H2O2 treatment step"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1704379:Treatment Step [Functional Concept]
           Step
   827   C1261552:Step [Conceptual Entity]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "should"

Phrase: "be"

Phrase: "performed with each experimental paradigm."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0681797:paradigm [Research Activity]
   760   C0884358:Performed [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.36: After blocking endogenous peroxidases, tissue was hydrated in ethanol (70, 50, and 30%) to 50 mM Tris-HCl, 0.15 M NaCl, pH 7.6 (TBS). 

Phrase: "After"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "endogenous peroxidases,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0031179:Peroxidases [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "hydrated in ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   790   C0720930:hydrated [Organic Chemical,Pharmacologic Substance]

Phrase: "(70,"

Phrase: "50,"

Phrase: "and"

Phrase: "30%"

Phrase: ")"

Phrase: "to 50 mM Tris-HCl,"

Phrase: "0.15 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.37: Dinitrophenyl Labeling Sections were covered with 0.10.001% DNP-H in 2 N HCl. 

Phrase: "Dinitrophenyl Labeling Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "covered with 0.10.001% DNP-H"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0439844:Covered [Functional Concept]
   753   C1120216:dinitrophenylhydrazine [Organic Chemical]
   753   C1999244:Covered [Functional Concept]
   719 E C0180153:cover [Medical Device]
   719 E C1707529:Cover [Medical Device]

Phrase: "in 2 N HCl."
Processing 00000000.tx.38: All incubations were done in a humidified plastic box. 

Phrase: "All incubations"

Phrase: "were"

Phrase: "done in a humidified plastic box."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0032167:Plastic [Substance]
   753   C0179400:Box [Manufactured Object]
   753   C1272695:Done [Qualitative Concept]
   753   C1533124:Box [Medical Device]
   753   C2746065:Done [Temporal Concept]
Processing 00000000.tx.39: After a 1-hr incubation at room temperature (RT), sections were exhaustively rinsed in TBS, followed by a 30-min incubation in 10% normal goat serum (NGS) to block nonspecific binding sites. 

Phrase: "After a 1-hr incubation"

Phrase: "at room temperature (RT), sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C2348236:ROOM TEMPERATURE [Qualitative Concept]

Phrase: "were"

Phrase: "exhaustively"

Phrase: "rinsed in TBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "followed by a 30-min incubation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "in 10% normal goat serum (NGS) to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0018019:goat [Mammal]
   804   C0205307:Normal [Qualitative Concept]
   804   C0229671:Serum [Body Substance]
   804   C0439166:% normal [Quantitative Concept]
   804   C1265549:goat [Mammal]
   804   C1510458:Goat [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C2347086:% Normal [Quantitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "nonspecific binding sites."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0005456:Binding Sites [Receptor]
   896   C0457192:Nonspecific site [Body Location or Region]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.40: After rinsing with 1% NGS/TBS, a rat monoclonal antibody (LO-DNP-2; Zymed, San Francisco, CA) to dinitrophenyl (DNP) was diluted 1:100 in 1% NGS/TBS and incubated with the sections at 4C for 16 hr. 

Phrase: "After"

Phrase: "rinsing with 1% NGS/TBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882955:Rinsing [Activity]

Phrase: "a rat monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(LO-DNP-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "; Zymed,"

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA) to dinitrophenyl (DNP)"

Phrase: "was"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 in 1% NGS/TBS"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0018019:goat [Mammal]
   748   C0205307:Normal [Qualitative Concept]
   748   C0229671:Serum [Body Substance]
   748   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   748   C0439166:% normal [Quantitative Concept]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1532188:Tbsp [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with the sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1439852:Incubated [Laboratory Procedure]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 16 hr."
Processing 00000000.tx.41: Sections were then rinsed with 1% NGS/TBS followed by goat antiserum to rat IgG (BoehringerMannheim; Indianapolis, IN) diluted 1:50 with 1% NGS/TBS. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed with 1% NGS/TBS"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0018019:goat [Mammal]
   748   C0205307:Normal [Qualitative Concept]
   748   C0229671:Serum [Body Substance]
   748   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   748   C0439166:% normal [Quantitative Concept]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1532188:Tbsp [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C2347086:% Normal [Quantitative Concept]
   714   C1701810:Rinse [Functional Concept]
   714   C1882955:Rinse [Activity]

Phrase: "followed by goat antiserum"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0018019:goat [Mammal]
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1265549:goat [Mammal]
   770   C1510458:Goat [Mammal]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "to rat IgG (BoehringerMannheim"

Phrase: "; Indianapolis,"

Phrase: "IN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50 with 1% NGS/TBS."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0018019:goat [Mammal]
   748   C0205307:Normal [Qualitative Concept]
   748   C0229671:Serum [Body Substance]
   748   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   748   C0439166:% normal [Quantitative Concept]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1532188:Tbsp [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.42: After rinsing in 1% NGS/TBS, rat peroxidaseanti-peroxidase complex (ICN) (1:250) in the same buffer was incubated with the section at RT for 1 hr, after which it was rinsed with 1% NGS/TBS. 

Phrase: "After"

Phrase: "rinsing in 1% NGS/TBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882955:Rinsing [Activity]

Phrase: "rat peroxidaseanti-peroxidase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(ICN) (1"

Phrase: ":"

Phrase: "250"

Phrase: ")"

Phrase: "in the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with the section"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205155:Section [Spatial Concept]
   770   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1522472:Section [Substance]
   770   C1552923:Section [Quantitative Concept]
   770   C1705191:Section [Physical Object]

Phrase: "at RT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "for 1 hr,"

Phrase: "after"

Phrase: "which it"

Phrase: "was"

Phrase: "rinsed with 1% NGS/TBS."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0018019:goat [Mammal]
   748   C0205307:Normal [Qualitative Concept]
   748   C0229671:Serum [Body Substance]
   748   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   748   C0439166:% normal [Quantitative Concept]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   748   C1532188:Tbsp [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C2347086:% Normal [Quantitative Concept]
   714   C1701810:Rinse [Functional Concept]
   714   C1882955:Rinse [Activity]
Processing 00000000.tx.43: Peroxidase activity was localized by development for 510 min with 0.015% H2O2 in 50 mM Tris-HCl, pH 7.6, with 0.75 mg/ml 3,3'-diaminobenzidine (Sigma). 

Phrase: "Peroxidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151518:peroxidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "localized by development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0392752:Localized [Spatial Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "for 510 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with 0.015% H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "in 50 mM Tris-HCl,"

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 0.75 mg/ml 3,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0439294:mg ml [Quantitative Concept]
   804   C0439269:mg% [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "3'-diaminobenzidine"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: Development of the sections was directly monitored for maximal contrast under the x10 objective of a Zeiss Axioskop 20 microscope. 

Phrase: "Development of the sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "monitored for maximal contrast"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]
   770   C1979874:Contrast [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "under the x10 objective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018017:Objective [Intellectual Product]
   861   C1571702:Objective [Qualitative Concept]

Phrase: "of a Zeiss Axioskop 20 microscope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]
Processing 00000000.tx.45: Chemical and immunochemical controls were used to define carbonyl-specific binding. 

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "and"

Phrase: "immunochemical controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "carbonyl-specific binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205369:Specific [Qualitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1552740:specific [Intellectual Product]
Processing 00000000.tx.46: Chemical reduction of free carbonyls and Schiff bases was performed by incubating sections with 25 mM sodium borohydride (NaBH4) in 80% methanol for 30 min at RT before incubation with DNP-H. 

Phrase: "Chemical reduction of free carbonyls"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0301630:Reduction, Chemical [Natural Phenomenon or Process]
           Reduction
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Schiff bases"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0036311:Schiff Bases [Organic Chemical]
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "was"

Phrase: "performed by incubating sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1439852:incubating [Laboratory Procedure]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with 25 mM sodium borohydride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0074728:sodium borohydride [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0006029:borohydride [Chemical Viewed Structurally]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(NaBH4"

Phrase: ")"

Phrase: "in 80% methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at RT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before incubation"

Phrase: "with DNP-H."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]
Processing 00000000.tx.47: Specific reduction of Schiff bases, while leaving carbonyls intact, was performed with 50 mM sodium cyanoborohydride in 0.1 M phosphate buffer, pH 6.0, for 1 hr at RT. 

Phrase: "Specific reduction of Schiff bases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "while"

Phrase: "leaving carbonyls"

Phrase: "intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "was"

Phrase: "performed with 50 mM sodium cyanoborohydride"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0074738:sodium cyanoborohydride [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in 0.1 M phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 6.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1 hr"

Phrase: "at RT."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.48: Immunochemical specificity was demonstrated by omission of the antibody to DNP or the DNP-H treatment. 

Phrase: "Immunochemical specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "demonstrated by omission of the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "the DNP-H treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.49: Immunoabsorption of the antibody to DNP was performed by incubating the antibody (1:100) with 5 mM pyruvate 2,4-dinitrophenylhydrazone (stock 1 mg/ml in ethanol) at 4C for 16 hr and comparing the resulting immunoreactivity with unabsorbed antibody that had been similarly treated with 5% ethanol. 

Phrase: "Immunoabsorption of the antibody"

Phrase: "to DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "performed by incubating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1439852:incubating [Laboratory Procedure]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "with 5 mM pyruvate 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "4-dinitrophenylhydrazone"

Phrase: "(stock 1 mg/ml in ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439294:mg ml [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 16 hr"

Phrase: "and"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the resulting immunoreactivity with unabsorbed antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "similarly"

Phrase: "treated with 5% ethanol."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001962:Ethanol [Organic Chemical]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.50: Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited DNP-H derivatizes free carbonyls on biomacromolecules, leading to DNP adduction to the carbonyl-containing biomacromolecule. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "DNP-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "derivatizes"

Phrase: "free carbonyls on biomacromolecules,"

Phrase: "leading to DNP adduction"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0231457:Adduction [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to the carbonyl-containing biomacromolecule."
Processing 00000000.tx.51: In contrast, reaction of DNP-H with Schiff bases formed between exogenous carbonyl compounds and proteinaceous lysine side-chains leads to release of soluble dinitrophenylhydrazones with no fixation of the DNP moiety to the tissue. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "reaction of DNP-H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443286:Reaction [Functional Concept]
   790   C1114821:Reaction [Clinical Attribute]

Phrase: "with Schiff bases"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0036311:Schiff Bases [Organic Chemical]
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "formed between exogenous carbonyl compounds"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0596258:carbonyl compounds [Organic Chemical]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C0205431:Formed [Functional Concept]
   726   C0205198:Compound [Qualitative Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
   726   C1706082:Compound [Chemical]

Phrase: "and"

Phrase: "proteinaceous lysine side-chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:chains [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chains [Idea or Concept]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release of soluble dinitrophenylhydrazones"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "with no fixation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185023:Fixation [Therapeutic or Preventive Procedure]
  1000   C0728733:fixation [Mental Process]
  1000   C1522662:Fixation [Laboratory Procedure]

Phrase: "of the DNP moiety"

Phrase: "to the tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.52: By examining the sites of DNP adduction from reaction with DNP-H, localization of oxidative damage at the cytological level can be achieved. 

Phrase: "By examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the sites of DNP adduction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "from reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "with DNP-H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "localization of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "at the cytological level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "achieved."
Processing 00000000.tx.53: Without subsequent antibody enhancement, DNP-H showed only faint yellow staining of the large blood vessels in the brains of aged individuals. 

Phrase: "Without subsequent antibody enhancement,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   827   C2349975:Enhancement [Activity]

Phrase: "DNP-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "faint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039070:Faint [Sign or Symptom]

Phrase: "yellow staining of the large blood vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C0005835:blood staining [Body Substance]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of aged individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.54: No staining of other brain cells or of the pathological changes of Alzheimer disease was seen (data not shown). 

Phrase: "No staining of other brain cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "or of the pathological changes of Alzheimer disease"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030664:Pathological [Biomedical Occupation or Discipline]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   744   C1521733:Pathological [Functional Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: DNP-H reaction and consequent DNP adduction to the walls of large vessels may not be surprising because extracellular matrix proteins abundant in vessels accumulate oxidative modifications, probably owing to their long half-life (Salomon et al. 1997 ). 

Phrase: "DNP-H reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "consequent DNP adduction to the walls of large vessels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0231457:Adduction [Functional Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "surprising"

Phrase: "because"

Phrase: "extracellular matrix proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079323:Extracellular Matrix Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "abundant in vessels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2346714:Abundant [Qualitative Concept]

Phrase: "accumulate"

Phrase: "oxidative modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "probably owing to their long half-life"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0018517:Half-Life [Temporal Concept]
   748   C0205166:Long [Qualitative Concept]
   748   C0376558:Life [Idea or Concept]
   748   C0750492:Probably [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2825407:Half [Quantitative Concept]

Phrase: "(Salomon et al. 1997"

Phrase: ")."
Processing 00000000.tx.56: Consistent with this interpretation, the large vessels of the aged individuals stained more intensely than those of the young (data not shown) (Salomon et al. 1997 ). 

Phrase: "Consistent with this interpretation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the large vessels of the aged individuals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0225990:Large vessels [Body Part, Organ, or Organ Component]
   748   C0005847:Vessels [Body Part, Organ, or Organ Component]
   714 E C1511228:Vessel [Tissue]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "more intensely than those of the young"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205172:More [Functional Concept]
   748   C0332239:Young [Temporal Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "(Salomon et al. 1997"

Phrase: ")."
Processing 00000000.tx.57: Although this assay was specific for free carbonyls, e.g., it is blocked with prior reduction of carbonyls with NaBH4, but not NaCNBH3, the value of the direct detection assay with DNP-H is limited because it does not detect the pathological sites of known oxidative damage in the lesions of Alzheimer disease. 

Phrase: "Although"

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "specific for free carbonyls,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "e.g."

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "blocked with prior reduction of carbonyls"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0028778:Blocked [Pathologic Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0332152:Prior [Temporal Concept]
   753   C0332206:Blocked [Functional Concept]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C2826257:PRIOR [Event]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "with NaBH4,"

Phrase: "but"

Phrase: "not NaCNBH3,"

Phrase: "the value of the direct detection assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "with DNP-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "because"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the pathological sites of known oxidative damage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "in the lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0221198:lesions [Finding]
   966 E C1546698:Lesion [Intellectual Product]

Phrase: "of Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.58: Therefore, sensitivity was increased by coupling the chemical reaction of DNP-H to an enzyme-linked immunocytochemical technique to detect bound DNP. 

Phrase: "Therefore,"

Phrase: "sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "was"

Phrase: "increased by coupling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1948027:Coupling [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the chemical reaction of DNP-H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0596319:chemical reaction [Phenomenon or Process]
   760   C0220806:Chemical [Chemical]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C3272558:Chemical [Intellectual Product]

Phrase: "to an enzyme-linked immunocytochemical technique to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449851:Technique [Functional Concept]
   721 E C0025664:techniques [Intellectual Product]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "bound DNP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.59: This method showed prominent DNP adduct formation not only in large vessels (not shown) but also in the cell bodies and apical dendrites of the pyramidal neurons of the hippocampus in cases of Alzheimer disease (Figure 1A and Figure 1C). 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "prominent DNP adduct formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "not only in large vessels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0225990:Large vessels [Body Part, Organ, or Organ Component]
   760   C0005847:Vessels [Body Part, Organ, or Organ Component]
   760   C0205171:Only [Quantitative Concept]
   760   C0549177:Large [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C1511228:Vessel [Tissue]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "but"

Phrase: "also in the cell bodies"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0599444:bodies cell [Cell Component]
   773 E C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:bodies [Human]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "apical dendrites of the pyramidal neurons of the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C3548420:apical dendrite [Cell Component]
   742   C0011305:Dendrites [Cell Component]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "Figure 1C"

Phrase: ")."
Processing 00000000.tx.60: In contrast, DNP adducts were undetectable in the neuronal cytoplasm of young or age-matched controls and in microvessels (Figure 1B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "DNP adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "undetectable in the neuronal cytoplasm of young"

Phrase: "or"

Phrase: "age-matched controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0001779:Age [Organism Attribute]
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "and in microvessels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C2350570:Microvessels [Body Part, Organ, or Organ Component]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.61: In addition to cytoplasmic staining of populations of large pyramidal neurons, intraneuronal neurofibrillary tangles were also recognized (Figure 1A, arrows). 

Phrase: "In addition to cytoplasmic staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "of populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "of large pyramidal neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0228072:Large neuron [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "intraneuronal neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "also"

Phrase: "recognized"

Phrase: "(Figure 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.62: Other populations of neurons, e.g., dentate granule cells, were also stained, but with lesser intensity. 

Phrase: "Other populations of neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "e.g."

Phrase: ","

Phrase: "dentate granule cells,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   867   C0596630:granule cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0010837:Granule [Cell Component]
   827   C0993609:Granule [Biomedical or Dental Material]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0205248:Granular [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ","

Phrase: "but with lesser intensity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0522510:Intensity [Qualitative Concept]
   770   C0547044:Lesser [Qualitative Concept]
Processing 00000000.tx.63: Senile plaques (including dystrophic neurites, -amyloid deposits, microglia, astrocytes, and adjacent oligodendrocytes) showed no reaction with DNP-H. 

Phrase: "Senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "dystrophic neurites, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "amyloid deposits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "microglia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206116:Microglia [Cell]
   928 E C0521398:Microglial [Body Location or Region]

Phrase: "astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "adjacent oligodendrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028944:Oligodendrocytes [Cell]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no reaction with DNP-H."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0442740:No reaction [Finding]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.64: View larger version (118K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.65: Free carbonyls were detected in cases of Alzheimer disease (A) not only in the pathological lesions of the disease, i.e., neurofibrillary tangles (arrows) but also in cytoplasm of neurons (large arrowheads). 

Phrase: "Free carbonyls"

Phrase: "were"

Phrase: "detected in cases of Alzheimer disease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0442726:Detected [Finding]
   753   C0868928:Cases [Functional Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(A)"

Phrase: "not only in the pathological lesions of the disease,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0012634:Disease [Disease or Syndrome]
   742   C0030664:Pathological [Biomedical Occupation or Discipline]
   742   C0205171:Only [Quantitative Concept]
   742   C0221198:lesions [Finding]
   742   C1518422:Not [Functional Concept]
   742   C1521733:Pathological [Functional Concept]
   742   C1720467:Only [Intellectual Product]
   708 E C1546698:Lesion [Intellectual Product]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "but"

Phrase: "also in cytoplasm of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   851   C1178979:Cytoplasm of neuron [Cell Component]
           Neuron cytoplasm
   760   C0010834:Cytoplasm [Cell Component]
   760   C0027882:Neurons [Cell]

Phrase: "(large arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.66: By contrast, in age-matched (B) and young controls none are labeled. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in age-matched"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001779:Age [Organism Attribute]
   861   C0150103:matched [Research Activity]
   861   C1708943:Matched [Qualitative Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "young controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "none"

Phrase: "are"

Phrase: "labeled."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.67: DNP-H adduction in a case of Alzheimer disease (C) is completely blocked by prior reduction by NaBH4 (D), omission of DNP-H, or adsorption of anti-DNP with DNP-pyruvate (E). 

Phrase: "DNP-H adduction in a case of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0231457:Adduction [Functional Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by prior reduction"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0028778:Blocked [Pathologic Function]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0332152:Prior [Temporal Concept]
   770   C0332206:Blocked [Functional Concept]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C2826257:PRIOR [Event]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "by NaBH4"

Phrase: "("

Phrase: "D)"

Phrase: ","

Phrase: "omission of DNP-H,"

Phrase: "or"

Phrase: "adsorption of anti-DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001674:Adsorption [Laboratory Procedure]

Phrase: "with DNP-pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.68: * indicates landmark present in each adjacent serial section (CE). 

Phrase: "*"

Phrase: "indicates"

Phrase: "landmark present in each adjacent serial section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "(CE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827664:CE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.69: Bars = 50 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.70: The specificity of the method to detect free carbonyls was demonstrated by chemical and immunochemical controls. 

Phrase: "The specificity of the method to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "free carbonyls"

Phrase: "was"

Phrase: "demonstrated by chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220806:Chemical [Chemical]
   790   C3272558:Chemical [Intellectual Product]

Phrase: "and"

Phrase: "immunochemical controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.71: In the former case, reduction of free carbonyls with NaBH4 blocked DNP-H binding (Figure 1D), whereas reduction of Schiff bases with NaCNBH3 was again without effect (not shown). 

Phrase: "In the former case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "reduction of free carbonyls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "with NaBH4"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "DNP-H binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "(Figure"

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "reduction of Schiff"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "bases with NaCNBH3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002055:base [Inorganic Chemical]
   790   C0178499:Base [Chemical Viewed Functionally]
   790   C1626935:Bases [Quantitative Concept]
   790   C1880279:Base [Biomedical or Dental Material]

Phrase: "was"

Phrase: "again without effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.72: Immunochemical validation was demonstrated by performing all of the following: omitting DNP-H treatment, omitting the antibody to DNP, or absorbing the antibody to DNP with the DNP-H derivative of pyruvate (Figure 1E). 

Phrase: "Immunochemical validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519941:Validation [Research Activity]

Phrase: "was"

Phrase: "demonstrated by performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0884358:Perform [Functional Concept]
   756   C2947996:Perform [Pharmacologic Substance]

Phrase: "all of the following"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0332283:follow [Temporal Concept]
   737   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "DNP-H treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "the antibody to DNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "absorbing"

Phrase: "the antibody to DNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "with the DNP-H derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "of pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(Figure 1E"

Phrase: ")."
Processing 00000000.tx.73: These immunochemical controls were critical to ensure the use of an antibody detection technique that is highly sensitive and specific, e.g., we found several different rabbit antisera to DNP that showed such high background staining for neurons that it was often difficult to note specific staining, whereas the rat monoclonal antibody showed no background staining. 

Phrase: "These immunochemical controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "critical to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511545:Critical [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "the use of an antibody detection technique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "highly sensitive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439822:Highly sensitive [Qualitative Concept]
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "e.g."

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "several different rabbit antisera to DNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "such high background staining for neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "often difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332183:Often [Temporal Concept]
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "specific staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "whereas"

Phrase: "the rat monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no background staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.74: Tissue was fixed in the non-crosslinking fixative Methacarn (methanol:chloroform:acetic acid 60:30:10), but we had similar results using unfixed or samples fixed in 80% ethanol. 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "fixed in the non-crosslinking fixative Methacarn"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0016184:Fixative [Indicator, Reagent, or Diagnostic Aid]
   748   C0066069:methacarn [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0178576:crosslinking [Natural Phenomenon or Process]
   748   C0231441:Fixed [Finding]
   748   C0443218:Fixed [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C2827483:Fixed [Body Substance]

Phrase: "(methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "chloroform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ":"

Phrase: "acetic acid 60"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "30"

Phrase: ":"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "had"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "unfixed"

Phrase: "or"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "fixed in 80% ethanol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001962:Ethanol [Organic Chemical]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]
Processing 00000000.tx.75: In contrast, tissue fixed in formaldehyde-based fixatives, as well as sections from tissue fixed in Methacarn but later treated with formaldehyde, displayed nonspecific DNP-H adduction throughout the section, making them unsuitable for study. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "fixed in formaldehyde-based fixatives,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0016184:Fixatives [Indicator, Reagent, or Diagnostic Aid]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2827483:Fixed [Body Substance]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as well as"

Phrase: "sections from tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   841   C2316368:Tissue section [Tissue]
   756   C0205155:Section [Spatial Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "fixed in Methacarn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0066069:methacarn [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "but"

Phrase: "later"

Phrase: "treated with formaldehyde,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "nonspecific DNP-H adduction throughout the section,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0231457:Adduction [Functional Concept]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "them unsuitable for study."
Processing 00000000.tx.76: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited 2,4-Dinitrophenylhydrazine (DNP-H), when coupled to immunochemical enhancement, can detect oxidative damage produced by a pathological condition, Alzheimer disease. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-Dinitrophenylhydrazine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: "(DNP-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120216:dinitrophenylhydrazine [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "when"

Phrase: "coupled to immunochemical enhancement,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C1948027:Coupled [Functional Concept]
   770   C2349975:Enhancement [Activity]
   737 E C0010222:couple [Family Group]

Phrase: "can"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "produced by a pathological condition,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0012634:condition [Disease or Syndrome]
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0348080:Condition [Qualitative Concept]
   760   C1521733:Pathological [Functional Concept]
   760   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.77: It is of interest that the adduction of DNP-H was limited to cell bodies of neurons. 

Phrase: "It"

Phrase: "is of"

Phrase: "interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "that"

Phrase: "the adduction of DNP-H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231457:Adduction [Functional Concept]

Phrase: "was"

Phrase: "limited to cell bodies of neurons."
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   860   C0599444:Cell body of neuron [Cell Component]
           neuron cell body
           bodies cell
   756 E C2752549:cell body [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0027882:Neurons [Cell]
   753   C0242821:bodies [Human]
   753   C0439801:Limited [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C1995017:Bodies [Cell Component]
   753   C3542948:Limited [Intellectual Product]
   750   C0682679:neuron body [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.78: This is essentially the same localization noted for adducts of the highly reactive lipid peroxidation product hydroxynonenal (Sayre et al. 1997 ) and for nitrotyrosine (Smith et al. 1997 ), the result of peroxynitrite-mediated damage. 

Phrase: "This"

Phrase: "is"

Phrase: "essentially"

Phrase: "the same localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "noted for adducts of the highly reactive lipid peroxidation product hydroxynonenal"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0023775:Lipid Peroxidation [Molecular Function]
   738   C0023779:Lipid [Lipid]
   738   C0178796:peroxidation [Phenomenon or Process]
   738   C0205250:Highly [Qualitative Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0596040:adducts [Chemical Viewed Structurally]
   738   C1514468:product [Entity]
   738   C1704444:Product [Quantitative Concept]
   704   C1316572:Note [Clinical Attribute]
   704   C1317574:Note [Intellectual Product]
   704   C1369612:Note [Clinical Attribute]

Phrase: "(Sayre et al. 1997"

Phrase: ")"

Phrase: "and for nitrotyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   790   C1515981:And [Idea or Concept]

Phrase: "(Smith et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "the result of peroxynitrite-mediated damage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
Processing 00000000.tx.79: In all these cases, neuronal cytoplasm showed evidence of damage whereas glia and senile plaques showed none. 

Phrase: "In all"

Phrase: "these cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "neuronal cytoplasm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1178979:Neuron cytoplasm [Cell Component]
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "whereas"

Phrase: "glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "and"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "none."
Processing 00000000.tx.80: Absence of oxidative damage in the senile plaque is surprising in light of reports that senile plaques are the source of oxygen radicals in Alzheimer disease. 

Phrase: "Absence of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the senile plaque"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   861   C0011389:Plaque [Disease or Syndrome]
   861   C0332461:Plaque [Finding]
   861   C0392079:Senile [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "is"

Phrase: "surprising in light of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "are"

Phrase: "the source of oxygen radicals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.81: First, -amyloid, the primary component of senile plaques, is suggested to produce free radicals through a novel mechanism (Butterfield et al. 1994 ). 

Phrase: "First, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the primary component of senile plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "free radicals through a novel mechanism"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   753   C0302912:radicals [Chemical Viewed Structurally]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0439807:Radical [Qualitative Concept]

Phrase: "(Butterfield et al. 1994"

Phrase: ")."
Processing 00000000.tx.82: Second, -amyloid interaction with the RAGE receptor of microglia leads to free radical production (Yan et al. 1996 ). 

Phrase: "Second, -amyloid interaction with the RAGE receptor of microglia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "leads to free radical production"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0033268:production [Occupational Activity]
   760   C0181586:leads [Medical Device]
   760   C0302912:Radical [Chemical Viewed Structurally]
   760   C0332296:free [Functional Concept]
   760   C0439807:Radical [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Yan et al. 1996"

Phrase: ")."
Processing 00000000.tx.83: Third, senile plaques accumulate iron, which may be available to generate hydroxyl radicals through Fenton chemistry (Grundke-Iqbal et al. 1990 ; Connor et al. 1992 ; Levine et al. 1994 ; Jefferies et al. 1996 ; Smith et al. 1997 ). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "accumulate"

Phrase: "iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "available to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]

Phrase: "generate"

Phrase: "hydroxyl radicals through Fenton chemistry"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0302912:Radicals (chemistry) [Chemical Viewed Structurally]
           radicals
   773   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   760   C0700307:Hydroxyl [Inorganic Chemical]
   726 E C0439807:Radical [Qualitative Concept]

Phrase: "(Grundke-Iqbal et al. 1990"

Phrase: "; Connor et al. 1992"

Phrase: "; Levine et al. 1994"

Phrase: "; Jefferies et al. 1996"

Phrase: "; Smith et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.84: Yet, when we examine free carbonyls, as here, lipid peroxide adducts (Sayre et al. 1997 ), or peroxynitrite-mediated damage (Smith et al. 1997 ), we find no increase in damage in senile plaques. 

Phrase: "Yet,"

Phrase: "when"

Phrase: "we"

Phrase: "examine"

Phrase: "free carbonyls,"

Phrase: "as"

Phrase: "here,"

Phrase: "lipid peroxide adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596040:adducts [Chemical Viewed Structurally]
   734   C0023776:lipid peroxide [Lipid]

Phrase: "(Sayre et al. 1997"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "peroxynitrite-mediated damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "(Smith et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "no increase in damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in senile plaques."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
Processing 00000000.tx.85: Absence of oxidative damage in senile plaques argues either that -amyloid and the surrounding cells are not susceptible to oxidative damage, that radical production by senile plaques is balanced by antioxidant defenses, or that some neuron-specific macromolecules are very susceptible to oxidation. 

Phrase: "Absence of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "argues"

Phrase: "either"

Phrase: "that -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the surrounding cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "not susceptible to oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "that radical production by senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "balanced by antioxidant defenses,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0003402:Antioxidant [Pharmacologic Substance]
   770   C0205415:Balanced [Functional Concept]
   770   C1880266:Defense [Conceptual Entity]
   737 E C0014653:Balance [Organism Function]
   737 E C0560184:Balance [Finding]

Phrase: "or"

Phrase: "that"

Phrase: "some neuron-specific macromolecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "very susceptible to oxidation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1550466:very susceptible [Idea or Concept]
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.86: Although it can be argued that -amyloid, because of its tight -structure and low lysine content, may be less susceptible than lysine-rich cytoskeletal proteins, cytoskeletal proteins also accumulate as paired helical filaments in the abnormal neurites surrounding senile plaques. 

Phrase: "Although"

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "argued"

Phrase: "that -amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "because of its tight -structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "low lysine content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "less susceptible than lysine-rich cytoskeletal proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0231204:Susceptible [Functional Concept]
   748   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "cytoskeletal proteins also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0010852:Cytoskeletal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867 E C1414120:cytoskeletal protein [Gene or Genome]
   827   C0010853:Cytoskeletal [Cell Component]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulate as paired helical filaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   828   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C1709450:Paired [Qualitative Concept]
   726   C0010851:Filament [Cell Component]

Phrase: "in the abnormal neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurites [Cell Component]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "senile plaques."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
Processing 00000000.tx.87: Why cytoskeletal proteins exhibit no oxidative damage in senile plaque neurites and do exhibit damage while in the neuronal cell body as neurofibrillary tangles is a major unresolved issue of our findings. 

Phrase: "Why cytoskeletal proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0010852:Cytoskeletal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867 E C1414120:cytoskeletal protein [Gene or Genome]
   827   C0010853:Cytoskeletal [Cell Component]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "no oxidative damage in senile plaque neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010957:Damage [Injury or Poisoning]
   748   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "do"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "while in the neuronal cell body"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0599444:neuronal cell body [Cell Component]
           Cell body
   790   C2752549:cell body [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C0750519:while [Idea or Concept]
   753   C1268086:Body [Anatomical Structure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C0682679:neuron body [Cell Component]

Phrase: "as neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "is"

Phrase: "a major unresolved issue of our findings."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1710575:Unresolved Issue [Idea or Concept]
   748   C0033213:Issue [Finding]
   748   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.88: Nevertheless, our results do not support the senile plaque as the primary site of free radical imbalance. 

Phrase: "Nevertheless,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the senile plaque as the primary site of free radical imbalance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   738   C0011389:Plaque [Disease or Syndrome]
   738   C0332461:Plaque [Finding]
   738   C0392079:Senile [Finding]
Processing 00000000.tx.89: Because reactive oxygen species (ROS) have short diffusion distances through tissue, our findings instead implicate an ROS source within the cell body. 

Phrase: "Because"

Phrase: "reactive oxygen species (ROS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "have"

Phrase: "short diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012222:Diffusion [Natural Phenomenon or Process]
   861   C1696141:Diffusion [Functional Concept]

Phrase: "distances through tissue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012751:Distance [Quantitative Concept]
   790   C0040300:Tissue [Tissue]
   790   C1547928:Tissue [Intellectual Product]

Phrase: "our findings instead"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "implicate"

Phrase: "an ROS source within the cell body."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449416:Source [Finding]
   742   C1705919:Source [Idea or Concept]
Processing 00000000.tx.90: Although the paired helical filaments might play this role (Yan et al. 1994 ; Smith et al. 1995a ), their absence in most neurons showing increased free carbonyls, as well as their presence in senile plaque neurites, does not strongly argue for their involvement in neuronal oxidative damage. 

Phrase: "Although"

Phrase: "the paired helical filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "this role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "(Yan et al. 1994"

Phrase: "; Smith et al. 1995a"

Phrase: ")"

Phrase: ","

Phrase: "their absence in most neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increased free carbonyls,"

Phrase: "as well as"

Phrase: "their presence in senile plaque neurites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "argue for their involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in neuronal oxidative damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
Processing 00000000.tx.91: Another possibility is mitochondria, because mitochondrial respiration is associated with ROS production and because significant mitochondrial abnormalities (Davis et al. 1997 ) and altered metabolism (Smith et al. 1997 ) are found in AD. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "because"

Phrase: "mitochondrial respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "is"

Phrase: "associated with ROS production"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0033268:production [Occupational Activity]
   753   C0205332:Reactive [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "because"

Phrase: "significant mitochondrial abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "(Davis et al. 1997"

Phrase: ")"

Phrase: "and"

Phrase: "altered metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(Smith et al. 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "are"

Phrase: "found in AD."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.92: In this regard, the specificity of damage to neuronal vs glial cytoplasm is expected if ROS depends on high metabolic activity, because neurons are among the most oxidative cells of the body. 

Phrase: "In this regard,"

Phrase: "the specificity of damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "to neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "vs"

Phrase: "glial cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "if"

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "depends on high metabolic activity,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205177:Activity [Functional Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0311400:Metabolic [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0725813:depend [Medical Device]
   760   C1299351:High [Qualitative Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C1561536:*Activity [Idea or Concept]
   760   C2700149:HIGH [Intellectual Product]
   760   C2707259:Metabolic [Clinical Attribute]

Phrase: "because"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are among the most oxidative cells of the body."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   762   C0599444:body cells [Cell Component]
   745 E C2752549:cell body [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0242821:body [Human]
   742   C0311404:Oxidative [Functional Concept]
   742   C0460148:Body [Anatomical Structure]
   742   C1268086:Body [Anatomical Structure]
   742   C1551058:Are [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.93: This, together with possible differences in either the susceptibility or the clearance of damaged proteins, may be responsible for the observed difference. 

Phrase: "This,"

Phrase: "together with possible differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in either"

Phrase: "the susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "or"

Phrase: "the clearance of damaged proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the observed difference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.94: It is tempting to speculate that neuronal damage involves not only the cytoskeletal proteins that bear glycoxidative (Ledesma et al. 1994 ; Yan et al. 1995 ) and lipoxidative (Smith et al., unpublished observation) adducts but also nuclear components. 

Phrase: "It"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that neuronal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "involves"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the cytoskeletal proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0010852:Cytoskeletal Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1414120:cytoskeletal protein [Gene or Genome]
   861   C0010853:Cytoskeletal [Cell Component]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "bear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "glycoxidative"

Phrase: "(Ledesma et al. 1994"

Phrase: "; Yan et al. 1995"

Phrase: ")"

Phrase: "and"

Phrase: "lipoxidative"

Phrase: "(Smith et al.,"

Phrase: "unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")"

Phrase: "adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "but"

Phrase: "also nuclear components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.95: Furthermore, the latter finding is consistent with the increased DNA fragmentation noted in Alzheimer disease (Su et al. 1994 ), because oxidative strand cleavage and repair of oxidative base modification are major causes of DNA fragmentation that may be incorrectly ascribed to apoptosis (Tsang et al. 1996 ). 

Phrase: "Furthermore,"

Phrase: "the latter finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the increased DNA fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "noted in Alzheimer disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(Su et al. 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705534:SU [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "oxidative strand cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "repair of oxidative base modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "major causes of DNA fragmentation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0015127:causes [Functional Concept]
   760   C0205164:Major [Qualitative Concept]
   760   C1314792:Causes [Functional Concept]
   726 E C1524003:Cause [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "incorrectly"

Phrase: "ascribed to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Tsang et al. 1996"

Phrase: ")."
Processing 00000000.tx.96: Our finding of increased neuronal DNP-H adduction is consistent with biochemical studies demonstrating increased DNP-H-derived adducts by assay of tissue homogenates from normal aging and Alzheimer disease (Smith et al. 1991 ). 

Phrase: "Our finding of increased neuronal DNP-H adduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with biochemical studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "demonstrating"

Phrase: "increased DNP-H-derived adducts by assay of tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "homogenates from normal aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001811:Ageing [Organism Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Smith et al. 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.97: However, in light of the large number of free carbonyls in the vasculature of all samples, particularly of the aged, the specificity and sensitivity of whole-tissue analysis to detect disease related increases, particularly for an age-related disease, are limited. 

Phrase: "However,"

Phrase: "in light of the large number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of free carbonyls"

Phrase: "in the vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "of all samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "particularly of the aged,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Aged [Organism Attribute]
   770   C0001792:Aged [Population Group]
   770   C1999167:aged [Population Group]

Phrase: "the specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "sensitivity of whole-tissue analysis to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0234235:Tissue sensitivity [Sign or Symptom]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
   748   C0332324:Sensitive to [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "disease related increases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "particularly for an age-related disease,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "are"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.98: Therefore, disease-related neuronal damage could be masked by damage to vessels when whole-tissue homogenates are used (Figure 2). 

Phrase: "Therefore,"

Phrase: "disease-related neuronal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "masked by damage"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0010957:Damage [Injury or Poisoning]
   790   C0150108:masked [Research Activity]
   790   C0150112:MASKED [Functional Concept]
   790   C1555580:masked [Idea or Concept]
   790   C1883709:Damage [Functional Concept]
   756 E C0024861:Mask [Medical Device]
   756 E C1538279:MASK [Gene or Genome]
   756 E C1845191:MASK [Gene or Genome]

Phrase: "to vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "when"

Phrase: "whole-tissue homogenates"

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(Figure 2"

Phrase: ")."
Processing 00000000.tx.99: View larger version (17K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.100: Schematic representation of the relationship between aging- (- - - - - - - -) and disease ()-related oxidative damage, showing that the accumulation of damage in long-lived extracellular matrix proteins (A) represents the vast majority of total modifications in tissue (C). 

Phrase: "Schematic representation of the relationship"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514861:Representation [Conceptual Entity]
   760   C1882932:Representation [Activity]

Phrase: "between aging-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "("

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: "-"

Phrase: ")"

Phrase: "and"

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: ")-"

Phrase: "related oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the accumulation of damage"

Phrase: "in long-lived extracellular matrix proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0079323:Extracellular Matrix Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   836   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the vast majority of total modifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "in tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.101: Therefore, using whole-tissue homogenates, disease-related increases () in neuronal carbonyls (B) might not be appreciated in relation to the total (C). 

Phrase: "Therefore,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-tissue homogenates,"

Phrase: "disease-related increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "("

Phrase: ")"

Phrase: "in neuronal carbonyls"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "appreciated in relation to the total"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0080103:Relation [Family Group]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0869014:relation [Social Behavior]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.102: Using in situ techniques as described herein, the increased neuronal carbonyls are readily apparent. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ techniques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]
   734   C0444498:In situ [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "herein,"

Phrase: "the increased neuronal carbonyls"

Phrase: "are"

Phrase: "readily apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.103: Note: Scale bars for carbonyls in A and C are a magnitude higher than in B. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: ":"

Phrase: "Scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0175659:Scale [Medical Device]
  1000   C0349674:Scale [Intellectual Product]
  1000   C1947916:Scale [Activity]
  1000   C3536777:Scale [Manufactured Object]
   928 E C1710017:Scalar [Qualitative Concept]
   916 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "bars for carbonyls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0687760:bar [Manufactured Object]
   790   C1551065:bar [Quantitative Concept]
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]

Phrase: "in A"

Phrase: "and"

Phrase: "C"

Phrase: "are"

Phrase: "a magnitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449286:magnitude [Quantitative Concept]
  1000   C1704240:Magnitude [Quantitative Concept]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.104: Another approach is to use the enhanced DNP-H immunochemical technique to identify specific proteins modified on immunoblots or by isolation (Smith et al. 1991 ; Shacter et al. 1994 ; Nakamura and Goto 1995 ). 

Phrase: "Another approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the enhanced DNP-H immunochemical technique to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449851:Technique [Functional Concept]
   721 E C0025664:techniques [Intellectual Product]

Phrase: "identify"

Phrase: "specific proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "modified on immunoblots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392747:Modified [Functional Concept]
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "or by isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "(Smith et al. 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: "; Shacter et al. 1994"

Phrase: "; Nakamura"

Phrase: "and"

Phrase: "Goto 1995"

Phrase: ")."
Processing 00000000.tx.105: Coupling of cytological and biochemical approaches not only may give greater specificity and sensitivity to oxidative damage measurement but may also lead to a greater appreciation of its dynamic nature. 

Phrase: "Coupling of cytological"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1948027:Coupling [Functional Concept]

Phrase: "and"

Phrase: "biochemical approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "may"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "greater specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "sensitivity to oxidative damage measurement"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0332324:Sensitive to [Functional Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "also"

Phrase: "lead to a greater appreciation of its dynamic nature."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0349590:Nature [Idea or Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C0729333:Dynamic [Functional Concept]
   742   C1262865:Nature [Functional Concept]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1704243:Greater [Quantitative Concept]
   742   C2346843:Appreciation [Conceptual Entity]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]
   708 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.106: Acknowledgments Supported by grants from the National Institutes of Health (AG09287, AG13846, and AG14249), by the Alzheimer's Association, and by the American Health Assistance Foundation. 

Phrase: "Acknowledgments"

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(AG09287,"

Phrase: "AG13846,"

Phrase: "and"

Phrase: "AG14249"

Phrase: ")"

Phrase: ","

Phrase: "by the Alzheimer's Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "and by the American Health Assistance Foundation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0016617:Foundation [Organization]
   748   C0018684:Health [Idea or Concept]
   748   C0018896:Assistance [Social Behavior]
   748   C0596070:American [Population Group]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.107: Received for publication June 4, 1997; 

Phrase: "Received for publication June 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.108: accepted January 7, 1998. 

Phrase: "accepted January 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998."
Processing 00000000.tx.109: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited Butterfield DA, Hensley K, Harris M, Mattson M, Carney J (1994) -amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Butterfield DA,"

Phrase: "Hensley K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Harris M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mattson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Carney J (1994"

Phrase: ") -"

Phrase: "amyloid peptide free radical fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0030935:Peptide Fragments [Amino Acid, Peptide, or Protein]
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "synaptosomal lipoperoxidation in a sequence-specific fashion"

Phrase: ":"

Phrase: "implications to Alzheimer's disease."
Processing 00000000.tx.110: Biochem Biophys Res Commun 200:710-715[Medline] Connor JR, Menzies SL, St. 

Phrase: "Biochem Biophys Res Commun 200"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "710-715"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Connor JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Menzies SL,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.111: Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. 

Phrase: "Martin SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Mufson EJ (1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1718783:Ej [Immunologic Factor]

Phrase: ")"

Phrase: "A histochemical study of iron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "transferrin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1442762:TRANSFERRIN [Gene or Genome]
   916 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ferritin in Alzheimer's diseased brains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.112: J Neurosci Res 31:75-83[Medline] Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD, Jr. 

Phrase: "J Neurosci Res 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450355:31 [Intellectual Product]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "75-83"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Miller S,"

Phrase: "Herrnstadt C,"

Phrase: "Ghosh SS,"

Phrase: "Fahy E,"

Phrase: "Shinobu LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Galasko D,"

Phrase: "Thal LJ,"

Phrase: "Beal MF,"

Phrase: "Howell N,"

Phrase: "Parker WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.113: (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutations in mitochondrial cytochrome c oxidase genes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0596611:gene mutations [Genetic Function]
   757   C2315666:Mitochondrial mutation [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "segregate with late-onset Alzheimer disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   814   C0814122:late disease onset [Finding]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.114: Proc Natl Acad Sci USA 94:4526-4531[Abstract/Free FullText] GrundkeIqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer disease. 

Phrase: "Proc Natl Acad Sci USA 94"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "4526-4531"

Phrase: "[Abstract/Free FullText"

Phrase: "] GrundkeIqbal I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fleming J,"

Phrase: "Tung YC,"

Phrase: "Lassmann H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iqbal K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Joshi JG"

Phrase: "(1990"

Phrase: ")"

Phrase: "Ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "a component of the neuritic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "(senile) plaque in Alzheimer disease."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   760   C0011389:Plaque [Disease or Syndrome]
   760   C0332461:Plaque [Finding]
   760   C0392079:Senile [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]
Processing 00000000.tx.115: Acta Neuropathol (Berl) 81:105-110[Medline] Jefferies WA, Food MR, Gabathuler R, Rothenberger S, Yamada T, Yasuhara O, McGeer PL (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "81"

Phrase: ":"

Phrase: "105-110"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jefferies WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Food MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Gabathuler R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rothenberger S,"

Phrase: "Yamada T,"

Phrase: "Yasuhara O,"

Phrase: "McGeer PL (1996"

Phrase: ")"

Phrase: "Reactive microglia specifically"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0206116:Microglia [Cell]
   755 E C0521398:Microglial [Body Location or Region]

Phrase: "associated with amyloid plaques"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Alzheimer's disease brain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0440746:Brain tissue [Tissue]
   861   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0040300:Tissue [Tissue]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "express"

Phrase: "melanotransferrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417130:MELANOTRANSFERRIN [Gene or Genome]
Processing 00000000.tx.116: Brain Res 712:122-126[Medline] Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. 

Phrase: "Brain Res 712"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "122-126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ledesma MD,"

Phrase: "Bonay P,"

Phrase: "Colaco C,"

Phrase: "Avila J (1994"

Phrase: ")"

Phrase: "Analysis of microtubule-associated protein tau glycation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in paired helical filaments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.117: J Biol Chem 269:21614-21619[Abstract/Free FullText] Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "21614-21619"

Phrase: "[Abstract/Free FullText"

Phrase: "] Levine RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Williams JA,"

Phrase: "Stadtman ER,"

Phrase: "Shacter E (1994"

Phrase: ")"

Phrase: "Carbonyl assays for determination of oxidatively modified proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.118: Methods Enzymol 233:346-357[Medline] Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ (1996) Crosslinking of apolipoprotein E by products of lipid peroxidation. 

Phrase: "Methods Enzymol 233"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "346-357"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Montine TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Huang DY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826182:DY [Temporal Concept]

Phrase: "Valentine WM,"

Phrase: "Amarnath V,"

Phrase: "Saunders A,"

Phrase: "Weisgraber KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Graham DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Strittmatter WJ"

Phrase: "(1996"

Phrase: ")"

Phrase: "Crosslinking of apolipoprotein E by products of lipid peroxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0178576:crosslinking [Natural Phenomenon or Process]
Processing 00000000.tx.119: J Neuropathol Exp Neurol 55:202-210[Medline] Nakamura A, Goto S (1995) Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. 

Phrase: "J Neuropathol Exp Neurol 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450382:55 [Intellectual Product]
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "202-210"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakamura A,"

Phrase: "Goto"

Phrase: "S ("

Phrase: "1995"

Phrase: ")"

Phrase: "Analysis of protein carbonyls"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1514534:Protein Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-dinitrophenyl hydrazine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020231:Hydrazine [Inorganic Chemical]
   827   C0020233:Hydrazine [Organic Chemical]

Phrase: "and"

Phrase: "its antibodies by immunoblot"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in two-dimensional gel electrophoresis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   923   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C1705052:2-Dimensional [Spatial Concept]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0205448:Two [Quantitative Concept]
   812   C1382104:Gel [Substance]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]
Processing 00000000.tx.120: J Biochem 119:768-774 Salomon RG, Subbanagounder G, ONeil J, Kaur K, Smith MA, Hoff HF, Perry G, Monnier VM (1997) Levuglandin E2-protein adducts in human plasma and vasculature. 

Phrase: "J Biochem 119"

Phrase: ":"

Phrase: "768-774 Salomon RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412999:RG [Gene or Genome]

Phrase: "Subbanagounder G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ONeil J,"

Phrase: "Kaur K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Smith MA,"

Phrase: "Hoff HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Monnier VM (1997"

Phrase: ")"

Phrase: "Levuglandin E2-protein adducts in human plasma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "vasculature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]
Processing 00000000.tx.121: Chem Res Toxicol 10:536-545[Medline] Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. 

Phrase: "Chem Res Toxicol 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0201682:CHEM [Laboratory Procedure]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "536-545"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Zelasko DA,"

Phrase: "Harris PLR,"

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Salomon RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Smith MA (1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "4-Hydroxynonenal-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "advanced lipid peroxidation end products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0444930:End [Spatial Concept]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "are"

Phrase: "increased in Alzheimer's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   773   C0277564:Acquired disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.122: J Neurochem 68:2092-2097[Medline] Shacter E, Williams JA, Lim M, Levine RL (1994) Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. 

Phrase: "J Neurochem 68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "2092-2097"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shacter E,"

Phrase: "Williams JA,"

Phrase: "Lim M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levine RL (1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419337:RL [Gene or Genome]
   827   C3539667:RL [Gene or Genome]

Phrase: ")"

Phrase: "Differential susceptibility of plasma proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to oxidative modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "examination by western blot immunoassay."
Processing 00000000.tx.123: Free Radic Biol Med 17:429-437[Medline] Smith CD, Carney JM, StarkeReed PE, Oliver CN, Stadtman ER, Floyd RA, Marksberry WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. 

Phrase: "Free Radic Biol Med 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "429-437"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith CD,"

Phrase: "Carney JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "StarkeReed PE,"

Phrase: "Oliver CN,"

Phrase: "Stadtman ER,"

Phrase: "Floyd RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Marksberry WR (1991"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1420193:WR [Gene or Genome]
   827   C1425679:WR [Gene or Genome]
   827   C1862190:WR [Immunologic Factor]
   827   C3538902:WR [Gene or Genome]

Phrase: ")"

Phrase: "Excess brain protein oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1159301:protein oxidation [Molecular Function]
   812   C0030011:Oxidation [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "enzyme dysfunction in normal aging"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and in Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.124: Proc Natl Acad Sci USA 88:10540-10543[Abstract] Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. 

Phrase: "Proc Natl Acad Sci USA 88"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "10540-10543"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smith MA,"

Phrase: "Harris PLR,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Beckman JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Perry G (1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Widespread peroxynitrite-mediated damage in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010957:Damage [Injury or Poisoning]
   748   C1883709:Damage [Functional Concept]
Processing 00000000.tx.125: J Neurosci 17:2653-2657[Abstract/Free FullText] Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. 

Phrase: "J Neurosci 17"

Phrase: ":"

Phrase: "2653-2657"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith MA,"

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Richey PL,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Anderson VE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: "Beal MF,"

Phrase: "Kowall N (1996"

Phrase: ")"

Phrase: "Oxidative damage in Alzheimer's."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]
Processing 00000000.tx.126: Nature 382:120-121[Medline] Smith MA, RudnickaNawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G (1995b) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. 

Phrase: "Nature 382"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "120-121"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith MA,"

Phrase: "RudnickaNawrot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Richey PL,"

Phrase: "Praprotnik D,"

Phrase: "Mulvihill P,"

Phrase: "Miller CA,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Perry G (1995b"

Phrase: ")"

Phrase: "Carbonyl-related posttranslational modification of neurofilament protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0033666:Protein Modification, Post-Translational [Molecular Function]
           Post-Translational Modification
           Protein Modification
   774   C2263112:protein modification [Molecular Function]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "in the neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.127: J Neurochem 64:2660-2666[Medline] Smith MA, Sayre LM, Monnier VM, Perry G (1995a) Radical AGEing in Alzheimer's disease. 

Phrase: "J Neurochem 64"

Phrase: ":"

Phrase: "2660-2666"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith MA,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Monnier VM,"

Phrase: "Perry G (1995a"

Phrase: ")"

Phrase: "Radical AGEing in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001811:Ageing [Organism Function]
Processing 00000000.tx.128: Trends Neurosci 18:172-176[Medline] Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 18"

Phrase: ":"

Phrase: "172-176"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith MA,"

Phrase: "Taneda S,"

Phrase: "Richey PL,"

Phrase: "Miyata S,"

Phrase: "Yan S-D,"

Phrase: "Stern D,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Monnier VM,"

Phrase: "Perry G (1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Advanced Maillard reaction end products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0444930:End [Spatial Concept]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "are"

Phrase: "associated with Alzheimer disease pathology."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0243083:associated disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.129: Proc Natl Acad Sci USA 91:5710-5714[Abstract] Stadtman ER (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "5710-5714"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stadtman ER (1993"

Phrase: ")"

Phrase: "Oxidation of free amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "amino acid residues in proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "by radiolysis"

Phrase: "and by metal-catalyzed reactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025552:Metal [Inorganic Chemical]
   760   C1515981:And [Idea or Concept]
   726   C0443286:Reaction [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.130: Annu Rev Biochem 62:797-821[Medline] Sternberger LA (1986) Immunocytochemistry. 

Phrase: "Annu Rev Biochem 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "797-821"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sternberger LA (1986"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023031:La [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "Immunocytochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]
Processing 00000000.tx.131: New York, Wiley Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Wiley Su JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268060:JH [Disease or Syndrome]
   827   C1415529:JH [Gene or Genome]

Phrase: "Anderson AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Cummings BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Cotman CW (1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454665:CW [Geographic Area]

Phrase: ")"

Phrase: "Immunohistochemical evidence for apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.132: Neuroreport 5:2529-2533[Medline] Szweda LI, Uchida K, Tsai L, Stadtman ER (1993) Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. 

Phrase: "Neuroreport 5"

Phrase: ":"

Phrase: "2529-2533"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Szweda LI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Uchida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tsai L,"

Phrase: "Stadtman ER (1993"

Phrase: ")"

Phrase: "Inactivation of glucose-6-phosphate dehydrogenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]
   716   C0017757:Glucose-6-Phosphate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1333652:GLUCOSE-6-PHOSPHATE DEHYDROGENASE [Gene or Genome]

Phrase: "by 4-hydroxy-2-nonenal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.133: Selective modification of an active-site lysine. 

Phrase: "Selective modification of an active-site lysine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.134: J Biol Chem 268:3342-3347[Abstract/Free FullText] Tsang SY, Tam SC, Bremner I, Burkitt MJ (1996) Copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3342-3347"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsang SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Tam SC,"

Phrase: "Bremner I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Burkitt MJ (1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: ")"

Phrase: "Copper-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2347872:Copper+ [Element, Ion, or Isotope]
   861   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "internucleosomal DNA fragmentation in HepG2 cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0376669:DNA Fragmentation [Molecular Function]
   753   C0332472:Fragmentation [Anatomical Abnormality]
   753   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "resulting from direct oxidation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0030011:Oxidation [Molecular Function]
   770   C0439851:Direct [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1947931:Direct [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "by the hydroxyl radical."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0439807:Radical [Qualitative Concept]
   861   C0700307:Hydroxyl [Inorganic Chemical]
Processing 00000000.tx.135: Biochem J 317:13-16[Medline] Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid- peptide neurotoxicity in Alzheimer's disease. 

Phrase: "Biochem J 317"

Phrase: ":"

Phrase: "13-16"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yan SD,"

Phrase: "Chen X,"

Phrase: "Fu J,"

Phrase: "Chen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Roher A,"

Phrase: "Slattery T,"

Phrase: "Zhao L,"

Phrase: "Nagashima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morser J,"

Phrase: "Migheli A,"

Phrase: "Nawroth P,"

Phrase: "Stern D,"

Phrase: "Schmidt AM (1996"

Phrase: ")"

Phrase: "RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034634:Rage [Mental Process]
  1000   C3539760:RAGE [Gene or Genome]

Phrase: "and"

Phrase: "amyloid- peptide neurotoxicity in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.136: Nature 382:685-691[Medline] Yan S-D, Chen X, Schmidt A-M, Brett J, Godman G, Zou Y-S, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen S-H, Stern D (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. 

Phrase: "Nature 382"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "685-691"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yan S-D,"

Phrase: "Chen X,"

Phrase: "Schmidt A-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Brett J,"

Phrase: "Godman G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zou Y-S, Scott CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0454665:CW [Geographic Area]

Phrase: "Caputo C,"

Phrase: "Frappier T,"

Phrase: "Smith MA,"

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S-"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Stern"

Phrase: "D ("

Phrase: "1994"

Phrase: ")"

Phrase: "Glycated tau protein in Alzheimer disease"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   783   C0373629:Glycated protein [Laboratory Procedure]
   783 E C1421563:protein tau [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: ":"

Phrase: "a mechanism for induction of oxidant stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.137: Proc Natl Acad Sci USA 91:7787-7791[Abstract] Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid -peptide. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "7787-7791"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yan SD,"

Phrase: "Yan SF,"

Phrase: "Chen X,"

Phrase: "Fu J,"

Phrase: "Chen M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kuppusamy P,"

Phrase: "Smith MA,"

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Godman GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Nawroth P,"

Phrase: "Zweier JL,"

Phrase: "Stern"

Phrase: "D ("

Phrase: "1995"

Phrase: ")"

Phrase: "Non-enzymatically glycated tau in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neuronal oxidant stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "resulting in cytokine gene expression"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0017262:Gene Expression [Genetic Function]
   806   C0332294:Resulting in [Functional Concept]
   806   C1333196:Cytokine Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "release of amyloid -peptide."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.138: Nature Med 1:693-699[Medline] Young HK, Floyd RA, Maidt ML, Dynlacht JR (1996) Evaluation of nitrone spin-trapping agents as radioprotectors. 

Phrase: "Nature Med 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "693-699"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Young HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "Floyd RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Maidt ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Dynlacht JR (1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Evaluation of nitrone spin-trapping agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "as radioprotectors."
Processing 00000000.tx.139: Radiat Res 146:227-231[Medline]

Phrase: "Radiat Res 146"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "227-231"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

